LifeScience Technologies LLC v. Mercy Health

District Court, E.D. Missouri·Decided September 30, 2024·No. 4:21-cv-01279·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION LIFESCIENCE TECHNOLOGIES, LLC ) ) Plaintiff, ) v. ) Case No. 4:21-cv-01279-SEP ) MERCY HEALTH, et al, ) ) Defendants. ) MEMORANDUM AND ORDER Before the Court are Plaintiff LST’s Motion to Compel Production of ESI from Two Additional Custodians, Doc. [216], Defendant Mercy’s Motion to Strike and Exclude LST’s Belatedly-Identified Proposed Witnesses, Doc. [251], and Mercy’s Motion to Deem Plaintiff LST’s Responses to Requests for Admission as Admitted, Doc. [290]. For the reasons set forth below, Plaintiff’s motion is granted and Defendant’s motions are denied. BACKGROUND This trade secret misappropriation case arises out of a dispute between LST and Defendants Mercy and Myia. LST is a software development company that develops and delivers virtual patient care solutions. Doc. [1] ¶ 19. One of LST’s virtual care platforms is m.Care, which connects hospital-based teams with home-based patients. Id. ¶¶ 19, 22. In 2015, Mercy asked LST to further develop its m.Care platform for use in Mercy’s patient population. Id. ¶ 30. Sometime in 2018, while Mercy was still using LST’s m.Care platform, Mercy announced that it was bringing Defendant Myia aboard to co-develop a virtual patient care platform for Mercy’s use. Id. ¶ 57. When Myia began working with Mercy, it did not have its own virtual care platform. Id. ¶ 59. Plaintiff alleges that Mercy improperly allowed Myia employees to access the m.Care platform in order to examine, reverse engineer, and use LST’s trade secrets and intellectual property to develop Myia’s software platform. Id. ¶¶ 60-77, 81. When Myia’s software was functionally capable of replacing the m.Care software, Mercy stopped using m.Care and began using Myia’s virtual care platform instead. Id. ¶ 86. Discovery in this matter has given rise to numerous disputes, which the Court has heard at informal discovery conferences. These motions follow. Additional information about each dispute will be set forth as necessary below. LEGAL STANDARD Federal Rule of Civil Procedure 26(b)(1) sets the scope for discovery: Parties may obtain discovery regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit. A party is not necessarily entitled to all discovery that is relevant, and courts may limit discovery “if the burden or expense of the proposed discovery outweighs its likely benefit,” if it “is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive,” and when “the party seeking discovery has had ample opportunity to obtain the information by discovery in the action.” Fed. R. Civ. P. 26(b)(2)(C). A party resisting discovery of relevant information bears the burden of showing why such information should not be produced. See Jo Ann Howard & Assoc., P.C. v. Cassity, 2013 WL 5335820, at *3 (E.D. Mo. Sept. 23, 2013). Under Rule 26(e) of the Federal Rules of Civil Procedure, a party who has disclosed information under Rule 26(a) or responded to an interrogatory, request for production or request for admission “must supplement or correct its disclosure or response . . . in a timely manner if the party learns that in some material respect the disclosure or response is incomplete or incorrect, and if the additional or corrective information has not otherwise been made known to the other parties during the discovery process of in writing.” Fed. R. Civ. P. 26(e). Whether a party has a duty to supplement is “committed to the sound discretion” of the court. Phil Crowley Steel Corp. v. Macomber, Inc., 601 F.2d 342, 344 (8th Cir. 1979). “If a party fails to provide information or identify a witness as required by Rule 26(a) or (e), the party is not allowed to use that information or witness to supply evidence on a motion, at a hearing, or at a trial, unless the failure was substantially justified or is harmless.” Fed. R. Civ. P. 37(c)(1). One purpose of discovery is to prevent unfair surprise, and “Rule 37’s enforcement mechanism helps accomplish this purpose.” Certain Underwriters at Lloyd’s v. SSDD, LLC, 301 F.R.D. 391, 393 (E.D. Mo. 2014) (citing Doe v. Young, 664 F.3d 727, 734 (8th Cir. 2011) (internal quotation marks omitted). However, “Rule 37 does not provide for mandatory sanctions,” and a district court may find that the failure to provide information was “substantially justified or harmless.” Radha Giesmann, MD, P.C. v. Am. Homepatient, Inc., 2017 WL 2709734, at *2 (E.D. Mo. June 22, 2017) (quoting Davis v. U.S. Bancorp, 383 F.3d 761, 765 (8th Cir. 2004)). The offending party has the burden to show the failure to disclose the witness was “substantially justified or harmless.” Id. (citation omitted). The district court considers the following four factors in determining whether a Rule 26 violation is justified or harmless, including: “(1) the prejudice or surprise to the party against whom the testimony is offered; (2) the ability of the party to cure the prejudice; (3) the extent to which introducing such testimony would disrupt the trial; and (4) the moving party’s bad faith or willfulness.” Rodrick v. Wal-Mart Stores East, L.P., 666 F.3d 1093, 1097-98 (8th Cir. 2012) (citation omitted). “[T]he Court need not make explicit findings concerning the existence of a substantial justification or the harmlessness.” Id. at 1097 (citation omitted). Indeed, the Court has “wide discretion to fashion a remedy or sanction appropriate for the particular circumstances of the case. Wegener v. Johnson, 527 F.3d 687, 692 (8th Cir. 2008). The Eighth Circuit has warned that “the exclusion of evidence is a harsh penalty and should be used sparingly.” ELCA Enters v. Sisco Equip. Rental & Sales, 53 F.3d 186, 190 (8th Cir. 1995). Rule 36 states in part that: A party may serve on any other party a written request to admit, for purposes of the pending action only, the truth of any matters within the scope of Rule 26(b)(1) relating to: facts, the application of law to fact, or opinions about either; and the genuineness of any described documents . . .. A matter is admitted unless, within 30 days after being served, the party to whom the request is directed serves on the requesting party a written answer or objection addressed to the matter and signed by the party or its attorney.

Fed. R. Civ. P. 36(a).

Free access — add to your briefcase to read the full text and ask questions with AI

LifeScience Technologies LLC v. Mercy Health, (E.D. Mo. 2024).

LifeScience Technologies LLC v. Mercy Health (LifeScience Technologies LLC v. Mercy Health) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related